Our new work in @JAHA_AHA - Pts without SMuRFs (DM, HTN, smoking & HLD) presenting with AMI had ⬆️ risk of all-cause mortality with ⬇️ prescription rate of GDMT. Need for discovery of new markers & mechanisms for early identification in this population.
https://t.co/u6Di7exRaf
Our analysis from the NORIN-STEMI registry published in @JACCJournals#JACCAsia provides insight into the epidemiology, practice patterns, outcomes, and sex differences in patients with STEMI in Northern India.
https://t.co/g9VRrRgCVu
In this MA of pts with cardiogenic shock requiring VA-ECMO support, concurrent use of Impella (ECPELLA) was associated with a lower risk of short-term mortality. However, pts with ECPELLA had higher rates of hemolysis, limb ischemia, and CRRT.
https://t.co/HQCt5YwXTh.
ICYMI: “We must increase awareness about heart attack symptoms and signs so that patients can get timely medical attention before it’s too late,” @aqamarmd@NorthShoreWeb@ESC_Journals#CardioTwitter https://t.co/Z13oXVWlde
Almost half of pts with STEMI in North India presented w moderate-severely reduced LVEF, and adherence to guideline directed therapies prescribed at discharge was low at 1 year. Systemic access to timely revasc and GDMT essential @AqamarMD@SameerAroraMD
https://t.co/9VItZBSwxt
Almost half of pts with STEMI in North India presented w moderate-severely reduced LVEF, and adherence to guideline directed therapies prescribed at discharge was low at 1 year. Systemic access to timely revasc and GDMT essential @AqamarMD@SameerAroraMD
https://t.co/9VItZBSwxt
Just published in @ESC_Journals our work on prognostic significance of obstructive coronary artery disease in patients admitted with ADHF.
A special thank you to @CaugheyPhD for her incredible mentorship.
https://t.co/lbYUIDm0VX